Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT futility study)
2015-000148-40Phase 3Completed
- Sponsor
- University Hospitals Plymouth
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing Simvastatin with Placebo (2 arms). Primary endpoint: Change in MDS-UPDRS part III motor score (OFF state) over 24 months. Started Sep 2015; status: completed.
02
Drugs
simvastatin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2015-000148-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000148-40.